Gufic Biosciences Limited (BOM:509079)
India
· Delayed Price · Currency is INR 276.85
-2.40 (-0.86%)
At close: Mar 9, 2026
Gufic Biosciences Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 27,763 | 33,738 | 28,394 | 18,095 | 24,129 | 8,896 | Upgrade
|
| Market Cap Growth | -31.32% | 18.82% | 56.92% | -25.01% | 171.24% | 142.42% | Upgrade
|
| Enterprise Value | 30,575 | 36,504 | 31,818 | 19,487 | 23,753 | 10,059 | Upgrade
|
| Last Close Price | 276.85 | 336.36 | 283.00 | 186.49 | 248.56 | 114.09 | Upgrade
|
| PE Ratio | 55.51 | 48.44 | 32.96 | 22.70 | 25.18 | 20.11 | Upgrade
|
| PS Ratio | 3.09 | 4.12 | 3.52 | 2.62 | 3.10 | 1.82 | Upgrade
|
| PB Ratio | 4.40 | 5.61 | 5.33 | 5.20 | 8.97 | 5.13 | Upgrade
|
| P/TBV Ratio | 4.44 | 5.67 | 5.39 | 5.21 | 8.99 | 5.14 | Upgrade
|
| P/FCF Ratio | - | 71.72 | - | - | 128.44 | 11.89 | Upgrade
|
| P/OCF Ratio | - | 27.53 | - | - | 22.71 | 10.20 | Upgrade
|
| EV/Sales Ratio | 3.41 | 4.45 | 3.94 | 2.82 | 3.05 | 2.06 | Upgrade
|
| EV/EBITDA Ratio | 24.13 | 27.87 | 22.37 | 14.91 | 16.61 | 12.51 | Upgrade
|
| EV/EBIT Ratio | 29.63 | 31.11 | 24.00 | 16.90 | 18.40 | 14.87 | Upgrade
|
| EV/FCF Ratio | - | 77.60 | - | - | 126.44 | 13.44 | Upgrade
|
| Debt / Equity Ratio | 0.59 | 0.56 | 0.63 | 0.96 | 0.24 | 0.36 | Upgrade
|
| Debt / EBITDA Ratio | 2.91 | 2.44 | 2.23 | 2.43 | 0.44 | 0.73 | Upgrade
|
| Debt / FCF Ratio | - | 7.15 | - | - | 3.43 | 0.82 | Upgrade
|
| Net Debt / Equity Ratio | 0.45 | 0.53 | 0.62 | 0.88 | 0.20 | 0.32 | Upgrade
|
| Net Debt / EBITDA Ratio | 2.35 | 2.45 | 2.33 | 2.34 | 0.37 | 0.69 | Upgrade
|
| Net Debt / FCF Ratio | - | 6.81 | -2.76 | -1.43 | 2.81 | 0.74 | Upgrade
|
| Asset Turnover | - | 0.73 | 0.83 | 1.00 | 1.71 | 1.22 | Upgrade
|
| Inventory Turnover | - | 1.83 | 2.08 | 2.27 | 4.01 | 2.37 | Upgrade
|
| Quick Ratio | - | 0.86 | 0.89 | 0.81 | 0.88 | 0.80 | Upgrade
|
| Current Ratio | - | 1.61 | 1.61 | 1.61 | 1.72 | 1.59 | Upgrade
|
| Return on Equity (ROE) | - | 12.29% | 19.57% | 25.84% | 43.31% | 29.22% | Upgrade
|
| Return on Assets (ROA) | - | 6.48% | 8.48% | 10.43% | 17.67% | 10.58% | Upgrade
|
| Return on Invested Capital (ROIC) | 8.31% | 9.72% | 13.01% | 17.66% | 35.43% | 21.59% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 15.00% | 18.40% | 20.10% | 38.50% | 29.60% | Upgrade
|
| Earnings Yield | 1.80% | 2.06% | 3.03% | 4.41% | 3.97% | 4.97% | Upgrade
|
| FCF Yield | - | 1.39% | -4.23% | -11.84% | 0.78% | 8.41% | Upgrade
|
| Dividend Yield | 0.04% | 0.03% | 0.03% | 0.05% | 0.04% | 0.09% | Upgrade
|
| Payout Ratio | - | 1.44% | 1.13% | 1.31% | 0.96% | 0.82% | Upgrade
|
| Buyback Yield / Dilution | -0.08% | -1.78% | -1.63% | - | - | -24.56% | Upgrade
|
| Total Shareholder Return | -0.05% | -1.75% | -1.59% | 0.05% | 0.04% | -24.47% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.